The Evolution in Pharmacology of Infectious Diseases: 2025

Building on the success of the inaugural edition, '"The Evolution in Pharmacology of Infectious Diseases: 2022"', this 2025 edition delves deeper into the latest advancements and emerging perspectives within a dynamic research landscape. Recent progress underscores the vital need for interdisciplinary collaboration and innovative methodologies to address the ever-evolving challenges posed by infectious diseases.

This Research Topic aims to highlight cutting-edge research, transformative scientific discoveries, and groundbreaking technological developments that are shaping infectious disease pharmacology in 2025. We invite original contributions offering novel scientific insights, technological innovations, and updated therapeutic strategies designed to tackle current challenges and enhance preparedness for future infectious threats. Our goal is to inform, inspire, and guide researchers, clinicians, and policymakers as they advance the field.
Potential topics of interest include, but are not limited to:

- Antimicrobial resistance: Novel strategies and approaches (including advances in pharmacokinetics and pharmacodynamics) to combat resistance.
- Artificial intelligence (AI) and machine learning: Pharmacological approaches that integrate AI and ML for accelerated drug discovery.
- Emerging & re-emerging infectious diseases.
- Drug repurposing: Strategies to expedite clinical translation and improve treatment outcomes.
- Genomic, proteomic, metabolomic, and bioinformatic tools to drive innovative diagnostics and treatments in infectious diseases
- COVID-19 and pandemic preparedness: Innovations in therapeutics, vaccination strategies, and lessons learned to inform future responses.
- Precision medicine for therapeutic optimization in infectious diseases.
- Neglected Tropical Diseases.
- HIV & opportunistic infections.
- Host-directed therapies: Approaches aimed at enhancing immune responses during infections.
- Nanomedicine: Advanced targeted delivery systems for antimicrobials, vaccines, immunomodulators, and treatments for microbial infections.
- HPV prevention & therapy: Recent developments, including innovative vaccine platforms.
- Economic and policy perspectives: Evaluations and multidisciplinary approaches influencing the evolution of pharmacological research in infectious diseases.

This collection provides a comprehensive, forward-looking perspective that will guide future research directions and clinical practices in the field of infectious disease pharmacology.

Keywords: Pharmacology, Infectious Diseases, Multidisciplinary Approach, Scientific Breakthroughs, Technological Advances, Pharmacokinetics, Antimicrobial Agents

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.